Skip to content
← Back to this collection

PUBLICATIONS · 19637348

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2009 Nov 15
First author
Chou AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Chou AJ
      type
      Author
    2. name
      Kleinerman ES
      type
      Author
    3. name
      Krailo MD
      type
      Author
    4. name
      Chen Z
      type
      Author
    5. name
      Betcher DL
      type
      Author
    6. name
      Healey JH
      type
      Author
    7. name
      Conrad EU 3rd
      type
      Author
    8. name
      Nieder ML
      type
      Author
    9. name
      Weiner MA
      type
      Author
    10. name
      Wells RJ
      type
      Author
    11. name
      Womer RB
      type
      Author
    12. name
      Meyers PA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Chou AJ
      type
      Author
    2. name
      Kleinerman ES
      type
      Author
    3. name
      Krailo MD
      type
      Author
    4. name
      Chen Z
      type
      Author
    5. name
      Betcher DL
      type
      Author
    6. name
      Healey JH
      type
      Author
    7. name
      Conrad EU 3rd
      type
      Author
    8. name
      Nieder ML
      type
      Author
    9. name
      Weiner MA
      type
      Author
    10. name
      Wells RJ
      type
      Author
    11. name
      Womer RB
      type
      Author
    12. name
      Meyers PA
      type
      Author
    bibliography ids
    1. nci-bib-a759237469960244251fc64b
    book metadata
    content sha256
    cf57d5cff83996663e53892dcfa3d77df54e0b2f25714c1a09a504f5601aa6c6
    document type
    citation
    dois
    1. 10.1002/cncr.24566
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19637348
    immutable id
    pubmed:19637348@cf57d5cff83996663e53892dcfa3d77df54e0b2f25714c1a09a504f5601aa6c6
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    22
    name
    Cancer
    nlm unique id
    0374236
    pages
    5339-48
    volume
    115
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19637348
      provenance
      batch id
      0706b5111d1451f52f74
      provider
      NCBI PubMed ESummary
      record sha256
      1bb95ada47c50bc91b11b5d0421c0307ed4f1077f0754ef4f0ea4254f49f8a6a
      response sha256
      98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
      retrieved at
      2026-09-09T23:46:29.215195+00:00
      publication date
      display
      2009 Nov 15
      precision
      day
      year
      2009
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19637348/
      title
      Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice